Likelihood of reporting adverse events in community pharmacy: an experimental study

被引:39
|
作者
Ashcroft, DM
Morecroft, C
Parker, D
Noyce, PR
机构
[1] Univ Manchester, Sch Pharm & Pharmaceut Sci, Ctr Innovat Practice, Manchester M13 9PL, Lancs, England
[2] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England
来源
QUALITY & SAFETY IN HEALTH CARE | 2006年 / 15卷 / 01期
关键词
D O I
10.1136/qshc.2005.014639
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: In the UK the National Reporting and Learning System (NRLS) is designed to coordinate the reporting of patient safety incidents nationally and to improve the ability of the health service to learn from the analysis of these events. Little is known about levels of engagement with the NRLS. Objective: To examine the likelihood of community pharmacists and support staff reporting patient safety incidents which occur in community pharmacies. Methods: Questionnaire survey containing nine incident scenarios. In the scenarios two factors were orthogonally manipulated: the outcome for the patient was reported as good, bad or poor, and the behaviour of the pharmacist was described as either complying with a protocol, not being aware of a protocol (error), or violating a protocol. Respondents were asked to rate whether they would report the incident (1) locally within the pharmacy and (2) nationally to the National Patient Safety Agency (NPSA). Results: 275 questionnaires were returned (79% response rate) from 223 community pharmacists and 52 members of support staff. There were significant main effects for both patient outcome (F(2,520) = 18.19, p < 0.001) and behaviour type (F(2,520) = 93.98, p, 0.001), indicating that pharmacists and support staff would take into account both the outcome of the behaviour and whether or not it follows a protocol when considering to report an incident within the pharmacy. Likewise, both pharmacists and support staff considered patient outcome (F(2,524) = 12.59, p, 0.001) and behaviour type (F(2,524) = 34.82, p, 0.001) when considering to report to the NPSA. Both locally and nationally, the likelihood of reporting any incident was low, and judgements on whether to report were more affected by the behaviour of the pharmacist in relation to protocols than the resulting outcome for the patient. Conclusions: Community pharmacists and their support staff would be unlikely to report adverse incidents if they witnessed them occurring in a community pharmacy. They remain to be convinced that the advantages to them and their patients outweigh the consequences of blame.
引用
收藏
页码:48 / 51
页数:4
相关论文
共 50 条
  • [31] Experiment of an anesthetic adverse events reporting
    Thevenin, A.
    Chenet, V.
    Schlumberger, S.
    Fischler, M.
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 2009, 28 (10): : 838 - 843
  • [33] Reporting adverse events in a war zone
    Arie, Sophie
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 361
  • [34] REPORTING ADVERSE EVENTS IN NURSING HOMES
    Wagner, L.
    Castle, N.
    Engberg, J.
    GERONTOLOGIST, 2009, 49 : 531 - 531
  • [35] Reporting Adverse Events for Cannabis to the FDA
    Hines, Michelle C.
    Harinstein, Lisa M.
    Kortepeter, Cindy M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (01): : 98 - 98
  • [36] Standards for assessing and reporting adverse events
    Kawakami, Takashi
    Kohsaka, Shun
    Sato, Yasunori
    Fukuda, Keiichi
    Matsubara, Hiromi
    LANCET RESPIRATORY MEDICINE, 2022, 10 (12): : E110 - E111
  • [37] Reporting of serious adverse events in neonates
    Mehta, U
    SOUTH AFRICAN MEDICAL JOURNAL, 2000, 90 (10): : 997 - 997
  • [38] Adverse drug effects in the community pharmacy
    Arnet, Isabelle
    Seidling, Hanna M.
    Hersberger, Kurt E.
    THERAPEUTISCHE UMSCHAU, 2015, 72 (11-12) : 687 - 692
  • [39] Suboptimal reporting of adverse medical events to the FDA Adverse Events Reporting System by nurse practitioners and physician assistants
    Ehrenpreis, Eli D.
    Sifuentes, Humberto
    Ehrenpreis, Jamie E.
    Smith, Zachary L.
    Marshall, Mike L.
    EXPERT OPINION ON DRUG SAFETY, 2012, 11 (02) : 177 - 183
  • [40] Improvement of the study, analysis, and reporting of adverse events associated with antiretroviral therapy
    Carr, A
    LANCET, 2002, 360 (9326): : 81 - 85